Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Ms E Walmsley
b)
Position/status
Chief Executive Officer
c)
Initial notification/ amendment

Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN: GB00BN7SWP63

b)
Nature of the transaction
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 6 October 2022 on Ordinary Shares held in the Company's Performance Share Plan subject to a 2-year holding period
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£13.2260
7,963.086
d)
Aggregated information
Aggregated volume
Price
N/A (single transaction)

e)
Date of the transaction
2022-10-10
f)
Place of the transaction
London Stock Exchange (XLON)
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr I Mackay
b)
Position/status
Chief Financial Officer
c)
Initial notification/ amendment

Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN: GB00BN7SWP63
b)
Nature of the transaction
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 6 October 2022 on Ordinary Shares held in the Company's Performance Share Plan subject to a 2-year holding period
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£13.2260
1,917.266
d)
Aggregated information
N/A (single transaction)
Aggregated volume
Price
e)
Date of the transaction
2022-10-10
f)
Place of the transaction
London Stock Exchange (XLON)

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

GSK plc published this content on 12 October 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 October 2022 11:41:02 UTC.